Biotech

Harvard Bioscience (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, announced today that the Company has completed the previously announced acquisition of Data Sciences International. As quoted in the press release: Simultaneous to the acquisition of DSI, the Company entered into a credit facility with Cerberus …

Harvard Bioscience (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, announced today that the Company has completed the previously announced acquisition of Data Sciences International.

As quoted in the press release:

Simultaneous to the acquisition of DSI, the Company entered into a credit facility with Cerberus Business Finance, LLC, as administrative agent and collateral agent for the lenders (the “Credit Facility”).  The Credit Facility is comprised of a $64 million term loan and a $25 million revolving line of credit, of which approximately $4.8 million was drawn at closing.

Click here to read the full press release.

Featured

MARKETS

Markets
TSX20748.58+216.40
TSXV724.19+9.53
DOW33212.96+575.77
S&P 5004158.24+100.40
NASD12131.13+390.48
ASX7105.90-49.30

COMMODITIES

Commodities
Gold1853.48+0.42
Silver22.12+0.10
Copper4.32+0.06
Palladium2076.57+68.57
Platinum957.08+8.08
Oil115.07+0.98
Heating Oil3.90+0.05
Natural Gas8.71-0.19

DOWNLOAD FREE REPORTS

×